Vanguard Group Inc Pro Phase Labs, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 408,267 shares of PRPH stock, worth $126,562. This represents 0.0% of its overall portfolio holdings.
Number of Shares
408,267
Previous 655,032
37.67%
Holding current value
$126,562
Previous $497,000
67.2%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PRPH
# of Institutions
34Shares Held
4.39MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT1.53MShares$472,9390.18% of portfolio
-
Four World Capital Management LLC New York, NY377KShares$116,7380.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny300KShares$92,9410.0% of portfolio
-
Geode Capital Management, LLC Boston, MA259KShares$80,3090.0% of portfolio
-
Josh Arnold Investment Consultant, LLC Edina, MN250KShares$77,5000.09% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.97M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...